Improving survival of critical care patients with coronavirus disease 2019 in England: a national cohort study, March to June 2020
Open accessPublished version of a preprint
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Objectives: To measure temporal trends in survival over time in people with severe coronavirus disease 2019 requiring critical care (high dependency unit or ICU) management, and to assess whether temporal variation in mortality was explained by changes in patient demographics and comorbidity burden over time. Design: Retrospective observational cohort; based on data reported to the COVID-19 Hospitalisation in England Surveillance System. The primary outcome was in-hospital 30-day all-cause mortality. Unadjusted survival was estimated by calendar week of admission, and Cox proportional hazards models were used to estimate adjusted survival, controlling for age, sex, ethnicity, major comorbidities, and geographical region. Setting: One hundred eight English critical care units. Patients: All adult (18 yr +) coronavirus disease 2019 specific critical care admissions between March 1, 2020, and June 27, 2020. Interventions: Not applicable. Measurements and Main Results: Twenty-one thousand eighty-two critical care patients (high dependency unit n = 15,367; ICU n = 5,715) were included. Unadjusted survival at 30 days was lowest for people admitted in late March in both high dependency unit (71.6% survival) and ICU (58.0% survival). By the end of June, survival had improved to 92.7% in high dependency unit and 80.4% in ICU. Improvements in survival remained after adjustment for patient characteristics (age, sex, ethnicity, and major comorbidities) and geographical region. Conclusions: There has been a substantial improvement in survival amongst people admitted to critical care with coronavirus disease 2019 in England, with markedly higher survival rates in people admitted in May and June compared with those admitted in March and April. Our analysis suggests this improvement is not due to temporal changes in the age, sex, ethnicity, or major comorbidity burden of admitted patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2. A, Adjusted hazard ratios (HRs) representing the relative change over time in-hospital mortality for people admitted to HDU and ICU with coronavirus disease 2019 (COVID-19) in England, up to the week of June 21, 2020. Bars represent 95% CIs. B, Relative mortality by week of hospital admission. An HR less than 1 reflects a lower mortality compared to patients admitted the week commencing March 29, 2020, which was used as the reference week as it was the peak week of COVID-19 admissions in COVID-19 Hospitalisation in England Surveillance System (CHESS). B, Average change in relative mortality per week, from the week of March 29, 2020, to the week of June 21, 2020, overall and for subgroups of patients. An HR less than 1 reflects a survival improvement. This figure shows that, for all patients, compared to people admitted during the week of March 29, 2020, for each subsequent week there was a 12.7% relative improvement in survival for high dependency unit (HDU) treated patients (adjusted HR for mortality 0.87 [95% CI 0.86-0.89]), and an 8.9% improvement in ICU treated patients (adjusted HR 0.91 [95% CI 0.89-0.93]). Similar improvements were seen across all age subgroups, in both men and women, and in people of White and Asian ethnicity. *HRs for mixed and other ethnicity defined subgroups not reported due to low patient numbers.](https://figures.cochat.ai/paper-figures/a9fcfe2b7f584b22896f24e0d93a8e1b/improving-survival-of-critical-care-patients-with-coronavirus-disease-2019-in-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475 · cited 1×
“Of particular note regarding treatment, the RECOVERY trial began nationwide recruitment in early April, and included dexamethasone which was later shown to have mortality-specific, or length of intensive treatment unit admission-specific benefits, as well as azithromycin, tocilizumab, and convalescent plasma (8).”
BackgroundRemdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267 · cited 1×
“Randomised Evaluation of COVID-19 Therapy (RECOVERY) did not include remdesivir, also shown to have therapeutic benefit in COVID-19 patients, but did not exclude patients receiving remdesivir or other potential COVID-19 treatments from the trial itself (9).”
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
Ferguson, N. M., Laydon, D. J., Nedjati-Gilani, G. L., Imai, N., Ainslie, K. E. C., Baguelin, M., Bhatia, S., Boonyasiri, A., Cucunubá, Z. M., Cuomo-Dannenburg, G., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/77482 · Cited by 3,281
Remdesivir for the Treatment of Covid-19 — Preliminary Report
(2020) · New England Journal of Medicine · doi:10.1056/nejmc2022236 · Cited by 1,396
Sprivulis, P. C., Da Silva, J., Jacobs, I. G., Jelinek, G. A., & Frazer, A. R. L. (2006) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00203.x · Cited by 759 · cited 1×
“Therefore, the observed time trend could be a manifestation of the well-established decline in patient-specific outcomes often observed at “unsafe” occupancy levels (11).”
BackgroundSprivulis, P. C., Da Silva, J., Jacobs, I. G., Frazer, A. R. L., & Jelinek, G. A. (2006) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00416.x · Cited by 757
Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland
Doidge, J. C., Gould, D. W., Ferrando-Vivas, P., Mouncey, P. R., Thomas, K., Shankar-Hari, M., Harrison, D. A., & Rowan, K. M. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202008-3212oc · Cited by 168 · cited 1×
“08] for peak vs pre-pandemic) (7); however, our analysis extends this observation to the HDU setting thereby demonstrating that this effect is likely to be robust to the selection bias implicit in identifying candidates for intensivist care.”
ResultMateen, B. A., Wilde, H., Dennis, J., Duncan, A., Thomas, N. J., McGovern, A. P., Denaxas, S., Keeling, M. J., & Vollmer, S. J. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-042945 · Cited by 65
Self-citation
Research works printed but not linked: 1
- RECOVERY Collaborative Group; Horby, 2020, N Engl J Med
Cited by
Severe covid-19 pneumonia: pathogenesis and clinical management
Attaway, A. H., Scheraga, R. G., Bhimraj, A., Biehl, M., & Hatipoğlu, U. (2021) · BMJ · doi:10.1136/bmj.n436 · Cited by 437
Barber, R. M., Sorensen, R. J. D., Pigott, D. M., Bisignano, C., Carter, A., Amlag, J. O., Collins, J. K., Abbafati, C., Adolph, C., Allorant, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00484-6 · Cited by 298
“Although these data suggest transmission to be somewhat lower at the highest levels of total immunity observed thus far, even with total immunity at 80%, we saw no indication of an abrupt drop in R effective .”
Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation
Long, B., Carius, B. M., Chavez, S., Liang, S. Y., Brady, W. J., Koyfman, A., & Gottlieb, M. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.01.028 · Cited by 252
Bennett, T. D., Moffitt, R. A., Hajagos, J. G., Amor, B., Anand, A., Bissell, M. M., Bradwell, K. R., Bremer, C., Byrd, J. B., Denham, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.16901 · Cited by 231
“7) (n = 3106) Hospital LOS, median (IQR), d NR NR 4 (2-8) (n = 25 906) 23 (12-37) (n = 2790) 9 (4-18) (n = 3775)”
Metadata
- Authors
- Dennis, J. M., McGovern, A. P., Vollmer, S. J., & Mateen, B. A.
- Affiliations
- University of Exeter (GB)
- University of Warwick (GB)
- Corresponding author
- Mateen, Bilal A.
- Venue
- Critical Care Medicine
- Published
- 2020-10-26
- Volume
- 49
- Issue
- 2
- Pages
- 209-214
- ISSN
- 0090-3493 (ISSN-L)
- PMC
- PMC7803441
- OpenAlex
- W3093584488
- Cited by
- 214
- References
- 15
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 6 · 2023: 22 · 2022: 51 · 2021: 112 · 2020: 13
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Critical Care Medicine (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Open Research Exeter (University of Exeter) (publishedVersion, cc-by)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion, cc-by)
- Funders
- Alan Turing Institute (N510129)
- National Institute for Health and Care Research (ACF-2017-23-003)
- University of Warwick
- Rosetrees Trust
- Engineering and Physical Sciences Research Council (N510129)
- Research England
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- COVID-19 pandemic, SARS-CoV-2, intensive care, in-hospital mortality, 30-day survival, temporal trends, high dependency unit, intensive care unit, comorbidities, patient demographics
- MeSH terms
- COVID-19, Adult, Aged, Critical Care, England, Female, Humans, Intensive Care Units, Male, Middle Aged, Retrospective Studies, Risk Factors, Cohort Studies, Survival Rate, Critical Illness, Survivors, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improving survival of critical care patients with coronavirus disease 2019 in England: a national cohort study, March to June 2020. https://app.cochat.ai/papers/10.1097/ccm.0000000000004747
- The paper
- Dennis, J. M., McGovern, A. P., Vollmer, S. J., & Mateen, B. A. (2021). Improving survival of critical care patients with coronavirus disease 2019 in England: a national cohort study, March to June 2020. Critical Care Medicine. https://doi.org/10.1097/ccm.0000000000004747
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.